At the time of writing, Biohaven Ltd [BHVN] stock is trading at $8.27, down -0.36%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BHVN shares have gain 6.16% over the last week, with a monthly amount drifted -48.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on November 06, 2025, when Bernstein downgraded its rating to a Mkt Perform but kept the price target unchanged to $9 for it. Previously, BofA Securities downgraded its rating to Neutral on November 05, 2025, and kept the price target unchanged to $10. On September 17, 2025, Citigroup initiated with a Buy rating and assigned a price target of $28 on the stock. Raymond James started tracking the stock assigning a Strong Buy rating and suggested a price target of $75 on September 03, 2025. RBC Capital Mkts downgraded its rating to a Sector Perform but $21 remained the price target by the analyst firm on May 19, 2025. Deutsche Bank started tracking with a Buy rating for this stock on February 11, 2025, and assigned it a price target of $65. In a note dated September 16, 2024, Jefferies initiated a Buy rating and provided a target price of $57 on this stock.
For the past year, the stock price of Biohaven Ltd fluctuated between $7.48 and $49.56. Currently, Wall Street analysts expect the stock to reach $42 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $8.27 at the most recent close of the market. An investor can expect a potential return of 407.86% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.91, Equity is -3.9 and Total Capital is -2.68. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-17.99.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.91 points at the first support level, and at 7.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.71, and for the 2nd resistance point, it is at 9.14.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 2.86. In addition, the Quick Ratio stands at 2.86 and the Cash Ratio stands at 1.64.
Transactions by insiders
Recent insider trading involved Bailey Gregory, Director, that happened on Nov 13 ’25 when 0.4 million shares were purchased. Director, CHILDS JOHN W completed a deal on Nov 13 ’25 to buy 3.33 million shares. Meanwhile, Chief Executive Officer Coric Vlad bought 0.67 million shares on Nov 13 ’25.
